R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This research is being done to see if a PET scan that is obtained after 3 cycles of a
standard chemotherapy regimen can help guide treatment for patients with a blood disease
called Non-Hodgkin's Lymphoma.
The standard treatment for newly diagnosed lymphoma is 6 to 8 cycles of chemotherapy like the
CHOP combination (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone). This regimen
can cure about half of patients with lymphoma, but in many others disease relapses (comes
back). Relapses are generally treated with more chemotherapy.
We believe that a PET scan (a type of imaging study that "lights up" in areas of cells with
high activity such as lymphoma), may identify patients early who are at high risk of relapse.
The purpose of this research study is to find out if people whose treatment is changed early
to an intensification regimen (high dose chemotherapy) based on a positive PET scan will have
longer remissions than they would if they did not receive that high dose chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins